KYTHERA Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/13/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Kythera Biopharmaceuticals (KYTH) PT Lifted to $61 at Leerink Partners; Takeout Value $85
March 12, 2015 6:30 AM EDTLeerink Partners analyst Seamus Fernandez lifted the price target on Outperform-rated Kythera Biopharmaceuticals (NASDAQ: KYTH) to $61.00 (from $50.00) on 2 factors: (1) rolling forward DCF and comparable valuation by 1 year consistent with our valuation analysis; and (2) inclusion of heavily risk-adjusted forecasts for recently in-licensed setipiprant for male-pattern... More
Kythera Biophrarma (KYTH) Prices $125M Common Offering at $48/Share
March 11, 2015 6:32 AM EDTAfter the close, Kythera Biophrarma (NASDAQ: KYTH) announced the pricing of its underwritten public offering of 2,604,168 shares of its common stock at a price to the public of $48.00 per share, before underwriting discounts and commissions and expenses of the offering, for gross proceeds of... More
